Can AI Stop Cancer Before It Starts? With: Dr. Azra Raza

Dr. Azra Raza, Professor of Medicine at Columbia University, challenges the cancer research community to shift focus from treating late-stage disease to detecting cancer at the 'first cell' stage. Drawing on decades of clinical work and a unique repository of 60,000 patient samples, she outlines how AI-powered, continuous monitoring could revolutionize early detection. Dr. Raza critiques the limitations of current models and screening methods, advocating for human-based research and proactive monitoring to prevent cancer before it requires invasive treatment. Her vision combines multi-omics analysis with implantable biosensors to identify biomarkers long before cancer reaches stage one, aiming to reduce suffering and improve outcomes.

 
 

About the Guest

Dr. Azra Raza is a Professor of Medicine at Columbia University and a leading oncologist, renowned for her work in myelodysplastic syndromes and early cancer detection.

 
 

Notable Quote

"Stage one is too late. We must detect cancer at the first cell stage to truly save lives."

 
 

Key Takeaways

  • Shift cancer focus from late treatment to early detection
  • Use AI to identify biomarkers before stage one
  • Human-based models outperform animal testing for accuracy
 
 

Transcript Summary

Q: Why focus on early cancer detection?
A: Current treatments target late-stage disease; detecting cancer at the first cell could prevent the need for harsh interventions.

Q: What's wrong with current research models?
A: Animal and artificial models often fail; studying human cells and tissues yields more relevant results.

Q: How can AI transform detection?
A: AI-powered devices could continuously monitor blood for early cancer biomarkers, detecting disease before stage one.

Q: What is the 'first cell' concept?
A: The earliest stage of cancer development, even before traditional diagnosis—targeting it allows for prevention, not just treatment.

Q: Why isn’t this widely implemented?
A: Funding and focus remain on treatment rather than prevention; systemic change and investment are needed.

 
 

About the Series

AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine.

Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine.

Mika Newton is an expert in healthcare data management, with a focus on data completeness and universality. Mika is on the editorial board of AI in Precision Oncology and is no stranger to bringing transformative technologies to market and fostering innovation.

 
 

Get new episode alerts via email

By clicking the Submit button, you agree to xCures's Terms of Service and Privacy Policy.